NSAIDs/nitazoxanide/azithromycin repurposed for COVID-19: potential mitigation of the cytokine storm interleukin-6 amplifier via immunomodulatory effects-Reference-Cited by-同舟云学术

NSAIDs/nitazoxanide/azithromycin repurposed for COVID-19: potential mitigation of the cytokine storm interleukin-6 amplifier via immunomodulatory effects

Published:2021-06-15 Issue:1 Volume:20 Page:17-21
ISSN:1478-7210
Container-title:Expert Review of Anti-infective Therapy
language:en
Short-container-title:Expert Review of Anti-infective Therapy

Author:

Kelleni Mina T.¹^ORCID

Affiliation:

1. Pharmacology Department, College of Medicine, Minia University, Egypt

Publisher

Informa UK Limited

Subject

Virology,Infectious Diseases,Microbiology (medical),Microbiology

Link

https://www.tandfonline.com/doi/pdf/10.1080/14787210.2021.1939683

Reference52 articles.

1. An update on SARS-CoV-2/COVID-19 with particular reference to its clinical pathology, pathogenesis, immunopathology and mitigation strategies

2. COVID-19: pathogenesis, advances in treatment and vaccine development and environmental impact—an updated review

Cited by 25 articles. 订阅此论文施引文献订阅此论文施引文献，注册后可以免费订阅5篇论文的施引文献，订阅后可以查看论文全部施引文献

1. An integrated bioinformatics approach reveals the potential role of microRNA-30b-5p and let-7a-5p during SARS CoV-2 spike-1 mediated neuroinflammation;International Journal of Biological Macromolecules;2024-10

2. The critical impacts of cytokine storms in respiratory disorders;Heliyon;2024-05

3. How do we change our approach to COVID with the changing face of disease?;Expert Review of Anti-infective Therapy;2024-04-26

4. Why Certain Repurposed Drugs Are Unlikely to Be Effective Antivirals to Treat SARS-CoV-2 Infections;Viruses;2024-04-22

5. COVID-19 mortality paradox (United States vs Africa): Mass vaccination vs early treatment;World Journal of Experimental Medicine;2024-03-20